|
US20030181355A1
(en)
*
|
1992-05-29 |
2003-09-25 |
Glenn Jeffrey S. |
Method for inhibition of viral infection
|
|
US5503973A
(en)
*
|
1992-05-29 |
1996-04-02 |
The Regents Of The University Of California |
Method for inhibition of viral morphogenesis
|
|
US7078391B2
(en)
*
|
1997-02-10 |
2006-07-18 |
Inspire Pharmaceuticals, Inc. |
Method of treating edematous retinal disorders
|
|
US7223744B2
(en)
*
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
|
US6818629B2
(en)
*
|
1997-02-10 |
2004-11-16 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
|
|
US6872710B2
(en)
*
|
1997-07-25 |
2005-03-29 |
Inspire Pharmaceuticals, Inc. |
Di(uridine 5′)-tetraphosphate and salts thereof
|
|
US20080108086A1
(en)
*
|
1999-06-02 |
2008-05-08 |
Cantor Thomas L |
Parathyroid hormone antagonists and uses thereof
|
|
WO2004028444A2
(en)
*
|
1999-06-02 |
2004-04-08 |
Scantibodies Laboratory, Inc. |
Parathyroid hormone antagonists and uses thereof
|
|
AUPQ105799A0
(en)
|
1999-06-18 |
1999-07-08 |
Victor Chang Cardiac Research Institute, The |
Cell growth inhibition
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
EP1365794A2
(en)
*
|
2000-07-21 |
2003-12-03 |
Lue, Tom |
Prevention and treatment of sexual arousal disorders
|
|
US7223406B2
(en)
|
2000-07-21 |
2007-05-29 |
The Regents Of The University Of California |
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
|
|
US6867199B2
(en)
*
|
2000-08-21 |
2005-03-15 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapeutic use
|
|
DE60220695T2
(de)
*
|
2001-09-04 |
2007-10-18 |
Dow Global Technologies, Inc., Midland |
Verfahren zum dispergieren eines fluidums in feststoffpartikeln
|
|
WO2003020207A1
(en)
*
|
2001-09-04 |
2003-03-13 |
Dow Global Technologies Inc. |
Aqueous air foam
|
|
CN1203055C
(zh)
|
2001-09-26 |
2005-05-25 |
朱德煦 |
治疗或预防细菌感染的方法和组合物
|
|
DK1572169T3
(da)
*
|
2002-03-08 |
2013-10-21 |
Shanghai Inst Biol Sciences |
Påvisning og modulering af Slit- og Robo-medieret angiogenese og anvendelser deraf
|
|
AU2003218600C1
(en)
|
2002-03-26 |
2009-12-17 |
Zensun (Shanghai) Science & Technology Co., Ltd. |
ERBB3 based methods and compositions for treating neoplasms
|
|
WO2003099320A1
(en)
|
2002-05-24 |
2003-12-04 |
Zensun (Shanghai) Sci-Tech.Ltd |
Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
|
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US8119150B2
(en)
*
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
AU2003279493B2
(en)
|
2002-10-25 |
2009-08-20 |
Foamix Pharmaceuticals Ltd. |
Cosmetic and pharmaceutical foam
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US7517887B2
(en)
*
|
2003-04-09 |
2009-04-14 |
General Atomics |
Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
|
|
US7868011B2
(en)
*
|
2003-04-09 |
2011-01-11 |
General Atomics |
Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
|
|
US7196093B2
(en)
*
|
2003-04-09 |
2007-03-27 |
General Atomics |
Reversible inhibitors of SAH hydrolase and uses thereof
|
|
US7575739B2
(en)
*
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
CA2538991A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Children's Medical Center Corporation |
Treatment of severe distal colitis
|
|
ES2552936T3
(es)
*
|
2003-12-12 |
2015-12-03 |
Otic Pharma Ltd. |
Composiciones para el tratamiento del desordenes en el oído y métodos para el uso de los mismos
|
|
US8940321B2
(en)
|
2003-12-12 |
2015-01-27 |
Otic Pharma Ltd. |
Compositions for treatment of ear disorders and methods of use thereof
|
|
US20050186271A1
(en)
*
|
2004-02-24 |
2005-08-25 |
Sheskey Paul J. |
Process for dispersing a fluid in a mass of solid particles
|
|
US8211449B2
(en)
*
|
2004-06-24 |
2012-07-03 |
Dpt Laboratories, Ltd. |
Pharmaceutically elegant, topical anhydrous aerosol foam
|
|
US20060147504A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Bobby Corry |
Feminine anti-itch cloth
|
|
WO2006080924A1
(en)
*
|
2005-01-27 |
2006-08-03 |
C.B. Fleet Company Incorporated |
Feminine anti-itch gel
|
|
MX2007014101A
(es)
|
2005-05-09 |
2009-02-13 |
Foamix Ltd |
Vehiculo espumable y composiciones farmaceuticas del mismo.
|
|
CN1869002A
(zh)
*
|
2005-05-27 |
2006-11-29 |
中国科学院上海药物研究所 |
一类非甾体雄激素受体调节剂、其制备方法和用途
|
|
CA2637408C
(en)
*
|
2006-01-19 |
2013-12-03 |
Disphar International B.V. |
Foam-forming composition
|
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
US20080299182A1
(en)
*
|
2007-03-01 |
2008-12-04 |
Shuyuan Zhang |
Methods and formulations for topical gene therapy
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
US9439857B2
(en)
|
2007-11-30 |
2016-09-13 |
Foamix Pharmaceuticals Ltd. |
Foam containing benzoyl peroxide
|
|
WO2009090495A2
(en)
|
2007-12-07 |
2009-07-23 |
Foamix Ltd. |
Oil and liquid silicone foamable carriers and formulations
|
|
US8518376B2
(en)
|
2007-12-07 |
2013-08-27 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
|
EP2242476A2
(en)
|
2008-01-14 |
2010-10-27 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
MX359879B
(es)
|
2009-10-02 |
2018-10-12 |
Foamix Pharmaceuticals Ltd |
Composiciones tópicas de tetraciclina.
|
|
US7888062B1
(en)
|
2010-02-01 |
2011-02-15 |
Microbios, Inc. |
Process and composition for the manufacture of a microbial-based product
|
|
US8445226B2
(en)
|
2010-02-01 |
2013-05-21 |
Microbios, Inc. |
Process and composition for the manufacture of a microbial-based product
|
|
CN104774804B
(zh)
|
2010-06-13 |
2018-10-26 |
中国科学院生物物理研究所 |
由干细胞制备心肌细胞的方法和组合物及其用途
|
|
WO2013053076A1
(en)
|
2011-10-10 |
2013-04-18 |
Zensun （Shanghai）Science & Technology Limited |
Compositions and methods for treating heart failure
|
|
CN104508121B
(zh)
|
2012-07-23 |
2018-01-19 |
中国科学院生物物理研究所 |
体外诱导多能干细胞分化为心室肌细胞的方法
|
|
CN109276705B
(zh)
|
2012-10-08 |
2023-10-20 |
上海泽生科技开发股份有限公司 |
治疗糖尿病患者心力衰竭的组份和方法
|
|
EP3610905B1
(en)
|
2013-05-22 |
2021-03-31 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Extended release of neuregulin for treating heart failure
|
|
EP3035903B1
(en)
|
2013-08-20 |
2018-08-22 |
Anutra Medical, Inc. |
Syringe fill system and method
|
|
USD750768S1
(en)
|
2014-06-06 |
2016-03-01 |
Anutra Medical, Inc. |
Fluid administration syringe
|
|
USD774182S1
(en)
|
2014-06-06 |
2016-12-13 |
Anutra Medical, Inc. |
Anesthetic delivery device
|
|
USD763433S1
(en)
|
2014-06-06 |
2016-08-09 |
Anutra Medical, Inc. |
Delivery system cassette
|
|
EP3430127A4
(en)
|
2016-03-18 |
2019-09-04 |
Institute of Biophysics Chinese Academy of Sciences |
CELL CULTURE MEDIUM AND CULTURE MEDIA SUPPLEMENT
|
|
CA2978573A1
(en)
|
2016-09-08 |
2018-03-08 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
|
CN113289002A
(zh)
|
2020-02-24 |
2021-08-24 |
上海泽生科技开发股份有限公司 |
神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物
|
|
US11447687B2
(en)
|
2020-09-29 |
2022-09-20 |
Saudi Arabian Oil Company |
Enhancing rheological properties of foam using aloe-barbadensis gel
|